Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease
medcases00
Published on Jul 23, 2021
Video Embed Original Content source - Glomerular Disease Study & Trial Consortium
https://www.youtube.com/channel/UC7FG1vWfVQSwOcJHO35lOAg
Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease
Chair, Jay B. Wish, MD, discusses advances in the management of anemia in chronic kidney disease in this CME/MOC/NCPD/CPE activity titled “Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science.†For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/UNQ865. CME/MOC/NCPD/CPE credit will be available until March 25, 2022.
- Your Subscription
medcases00 -
Share Video
Add to
Flag Video
Rate video
Rate video
Up next
Autoplay
Recommended
-
56:07
KDIGO Optimal Anemia Management in CKD: A New Paradigm in Treatment?
16 views 1085 days ago -
01:01:37
HIF-PHIs for the Treatment of Anemia in CKD: Ready or Not?
13 views 1075 days ago -
56:14
Chronic Kidney Disease: Considerations in the Management of Metabolic Acidosis
13 views 1270 days ago -
32:26
Ian de Boer, MD, MS - Continuous Glucose Monitoring in Chronic Kidney Disease
16 views 1088 days ago -
33:01
Eric Luitweiler, MD - Alkali Therapy in Chronic Kidney Disease
16 views 1045 days ago -
01:10:19
New Understandings in the Pathophysiology of Anemia in CKD with Dr. Jim Sloand
14 views 793 days ago